Diagnostic	JJ
Values	NNS
For	IN
Club	NNP
Cell	NNP
Secretory	NNP
Protein	NN
(	(
CC16	NN
)	)
in	IN
Serum	NN
of	IN
Patients	NNS
of	IN
Combined	JJ
Pulmonary	JJ
Fibrosis	NN
and	CC
Emphysema	NN
.	.

Combined	VBN
pulmonary	JJ
fibrosis	NN
and	CC
emphysema	NN
(	(
CPFE	NN
)	)
is	VBZ
an	DT
under-recognized	JJ
syndrome	NN
for	IN
which	WDT
the	DT
diagnostic	JJ
use	NN
of	IN
serum	NN
biomarkers	NNS
is	VBZ
an	DT
attractive	JJ
possibility	NN
.	.

We	PRP
hypothesized	VBD
that	IN
CC16	NN
and/or	CC
TGF-b1	NN
or	CC
combinations	NNS
with	IN
other	JJ
biomarkers	NNS
are	VBP
useful	JJ
for	IN
diagnosing	VBG
CPFE	NNP
.	.

Patients	NNS
with	IN
respiratory	JJ
symptoms	NNS
and	CC
a	DT
smoking	NN
history	NN
,	,
with	IN
or	CC
without	IN
chronic	JJ
obstructive	JJ
pulmonary	JJ
disease	NN
,	,
were	VBD
divided	VBN
into	IN
the	DT
following	VBG
three	CD
groups	NNS
according	VBG
to	TO
findings	NNS
of	IN
high-resolution	JJ
computed	VBN
tomography	NN
of	IN
the	DT
chest	NN
:	:
controls	NNS
without	IN
either	CC
emphysema	NN
or	CC
fibrosis	NN
,	,
patients	NNS
with	IN
emphysema	NN
alone	RB
,	,
and	CC
patients	NNS
compatible	JJ
with	IN
the	DT
diagnosis	NN
of	IN
CPFE	NN
.	.

Serum	NN
concentrations	NNS
of	IN
CC16	NN
,	,
TGF-b1	NN
,	,
SP-D	NN
,	,
and	CC
KL-6	NN
were	VBD
measured	VBN
in	IN
patients	NNS
whose	WP$
condition	NN
was	VBD
stable	JJ
for	IN
at	IN
least	JJS
3	CD
months	NNS
.	.

To	TO
investigate	VB
changes	NNS
in	IN
biomarkers	NNS
of	IN
lung	NN
fibrosis	NN
in	IN
patients	NNS
with	IN
a	DT
life-long	JJ
smoking	NN
history	NN
,	,
additional	JJ
measurements	NNS
were	VBD
performed	VBN
on	IN
the	DT
patients	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
of	IN
smoking	NN
history	NN
.	.

The	DT
mean	NN
age	NN
of	IN
the	DT
first	JJ
three	CD
groups	NNS
was	VBD
68.0	CD
years	NNS
,	,
whereas	IN
that	DT
of	IN
the	DT
IPF	NN
group	NN
was	VBD
71.8	CD
years	NNS
,	,
and	CC
the	DT
groups	NNS
contained	VBD
36	CD
,	,
115	CD
,	,
27	CD
,	,
and	CC
10	CD
individuals	NNS
,	,
respectively	RB
.	.

The	DT
serum	NN
concentration	NN
of	IN
CC16	NN
in	IN
the	DT
four	CD
groups	NNS
was	VBD
5.67	CD
0.42	CD
,	,
5.66	CD
0.35	CD
,	,
9.38	CD
1.04	CD
and	CC
22.15	CD
4.64	CD
ng/ml	NN
,	,
respectively	RB
,	,
indicating	VBG
that	IN
those	DT
patients	NNS
with	IN
lung	NN
fibrosis	NN
had	VBD
a	DT
significantly	RB
higher	JJR
concentration	NN
.	.

The	DT
combined	VBN
use	NN
of	IN
CC16	NN
,	,
SP-D	NN
,	,
and	CC
KL-6	NN
provided	VBD
supportive	JJ
diagnosis	NN
in	IN
conjunction	NN
with	IN
radiological	JJ
imaging	NN
in	IN
diagnosis	NN
of	IN
CPFE	NN
.	.

We	PRP
conclude	VBP
that	IN
a	DT
combination	NN
of	IN
biomarkers	NNS
including	VBG
CC16	NN
could	MD
provide	VB
useful	JJ
information	NN
to	TO
screen	NN
and	CC
predict	VBP
the	DT
possible	JJ
diagnosis	NN
of	IN
CPFE	NN
.	.

